Dr Lal Pathlabs announces acquisition of two pathology labs

Dr Lal Pathlabs announced that its wholly owned subsidiary, PathLabs Unifiers has signed binding term sheets on 6 November, 2020 for the acquisitions of the business of Bindish Diagnostic Laboratory LLP (BDL), in Jamnagar, Gujarat on a going concern basis, for a purchase consideration not exceeding Rs 4 crore and equity stake of 70% in ChanRe Diagnostic Services (CDSPL), in Bengaluru, Karnataka, for a purchase consideration not exceeding Rs 17.5 crore. BDL and CDSPL are engaged in the business of providing pathological diagnostic services

Powered by Capital Market - Live News